Navigation Links
Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Date:5/12/2008

CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 12:00 p.m. CEST at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceutical Contact:

Ron Renaud (617) 995-9800


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Oven Industries announces ... the integrated potentiometers or via a PC through the ... two and one half inches square can deliver up ... voltage switched, low noise solid state relay. Operator safety ... for the communication port and sensor input. Specifications: ...
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... the 3rd Annual Disruptive Innovations to Advance Clinical Trials ... Copley Plaza Hotel in Boston, MA. , Disruptive ... Janssen Pharmaceuticals and more share bold approaches to reduce ... , “Disruptive innovation needs to be big, or ...
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... May 22, 2013 Mold remediation could take ... that there is a way to cut down the process' ... its latest post the details of a method how ... , Mold could be prevented, My Cleaning Products said. But ... stated that a mold remediation must then be promptly implemented ...
Breaking Biology Technology:New AC Temperature Controller Announced by Oven Industries 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2
... The Board of Directors of Schering-Plough Corporation (NYSE: SGP ... share. Payment will be made on Nov. 30, 2009, to ... 2009. As of June 30, 2009, there were 1,633,938,697 common ... Directors today also declared a quarterly dividend of $3.75 per share ...
... , , TUSTIN, Calif., ... US-based pharmaceutical company with major assets in China, announced today its stockholders ... Company as " Radient Pharmaceuticals Corporation" . The new ... "RPC" . The Company has filed an amendment to ...
... CINCINNATI, Sept. 18 LCA-Vision Inc. (Nasdaq: ... services under the Lasik Plus (R) brand, announces that Steven ... member of the company,s board of directors effective September 25, ... industry. Management of daily operations will be the responsibility ...
Cached Biology Technology:AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 2AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 3AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 4AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US 5LCA-Vision Announces CEO Resignation 2
(Date:5/21/2013)... Northwestern University researchers have developed a new method ... temporary holes in the cell surface. The technique ... and related biological fields. , Bulk electroporation ... through reversible nanopores in the cell membrane that ... is an increasingly popular method of cell ...
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... world,s largest scientific society, invites news media coverage ... 8-12, 2013, in Indianapolis, Ind. It will take ... area hotels. , With more than 7,100 presentations ... from astronomy to zoology ― the meeting will ... assortment of spot news and feature possibilities. The ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Common food supplement fights degenerative brain disorders 2
... reported at the second European Lung Cancer Conference ... and small-cell lung cancer benefit in terms of ... radiotherapy. Patients treated with hyperfractionated or accelerated ... and over a shorter period of time. The ...
... allows precise targeting of radiotherapy using real-time X-ray images has ... administered to lung and liver cancers while minimizing harm to ... Cancer Conference. "With this study we show that it ... that can give information at any time before or during ...
... this latest image acquired by ESA,s Envisat on Thursday at ... of Mexico can be seen as a dark blue swirl ... oil spill five times larger than first estimated ... threatening environmental disaster. , As efforts are being made by ...
Cached Biology News:Meta-analysis: Radiotherapy variants improve survival in non-metastatic lung cancer 2Oil spill in the Gulf of Mexico nears the coast 2
Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead, 2 g. Category: Leadseeker Beads....
... High Five cells (BTI-TN-5B1-4) derived from ... been shown to be capable of ... recombinant proteins compared to other insect ... following features:- -Rapid doubling time as adherent ...
Sf9 cells derived from Spodoptera frugiperda ovarian cells (Sf21 cells) are commonly used to isolate and propagate recombinant AcMNPV viral stocks and to produce recombinant proteins....
... BacVector Insect Cell Medium is optimized ... Ea4 Insect Cells. In this protein-free medium, ... 1 * 107 cells/ml with viabilities above ... plaque assays, where color from X-gluc staining ...
Biology Products: